Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Feun

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
American Journal of Clinical Oncology|December 1, 1990
Hypercalcemia and malignant melanomaI Levy, L Feun
Health Education|August 1, 1984
TLC--tender loving care for tender living cargo: an innovative approach to child passenger safety in a local health departmentE B McCooey, L Feun
Journal of Neuro-Oncology|January 1, 1994
Neurologic complications of Merkel cell carcinomaS M Snodgrass, H Landy, A M Markoe, et al.
Journal of Neuro-Oncology|August 10, 2000
Early MRI findings in high grade gliomaH J Landy, T T Lee, P Potter, et al.
Investigational New Drugs|January 1, 1997
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderM Khorsand, J Lange, L Feun, et al.
International Journal of Oncology|May 17, 2011
Cytogenetic studies on the in-vitro genotoxicity of 4-nitroquinoline-1-oxide on human-lymphocytesT Hsu, N Savaraji, Z Trizna, et al.
Acta Neurochirurgica. Supplement|January 1, 1994
Long-term follow-up of gliomas treated with fractionated stereotactic irradiationH J Landy, J G Schwade, P V Houdek, et al.
Southern Medical Journal|February 1, 1994
Retreatment of intracranial gliomasH J Landy, L Feun, J G Schwade, et al.
Critical Reviews in Oncogenesis|April 14, 1999
Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)L E Raez, P Patel, L Feun, et al.
Current Pharmaceutical Design|May 14, 2008
Arginine deprivation as a targeted therapy for cancerL Feun, M You, C J Wu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
American Journal of Clinical Oncology|December 1, 1990
Hypercalcemia and malignant melanomaI Levy, L Feun
Health Education|August 1, 1984
TLC--tender loving care for tender living cargo: an innovative approach to child passenger safety in a local health departmentE B McCooey, L Feun
Journal of Neuro-Oncology|January 1, 1994
Neurologic complications of Merkel cell carcinomaS M Snodgrass, H Landy, A M Markoe, et al.
Journal of Neuro-Oncology|August 10, 2000
Early MRI findings in high grade gliomaH J Landy, T T Lee, P Potter, et al.
Investigational New Drugs|January 1, 1997
Phase II trial of oral piritrexim in advanced, previously treated transitional cell cancer of bladderM Khorsand, J Lange, L Feun, et al.
International Journal of Oncology|May 17, 2011
Cytogenetic studies on the in-vitro genotoxicity of 4-nitroquinoline-1-oxide on human-lymphocytesT Hsu, N Savaraji, Z Trizna, et al.
Acta Neurochirurgica. Supplement|January 1, 1994
Long-term follow-up of gliomas treated with fractionated stereotactic irradiationH J Landy, J G Schwade, P V Houdek, et al.
Southern Medical Journal|February 1, 1994
Retreatment of intracranial gliomasH J Landy, L Feun, J G Schwade, et al.
Critical Reviews in Oncogenesis|April 14, 1999
Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL)L E Raez, P Patel, L Feun, et al.
Current Pharmaceutical Design|May 14, 2008
Arginine deprivation as a targeted therapy for cancerL Feun, M You, C J Wu, et al.
Pageof 3